Omeros forms oncology committee to guide development of its AML therapy, which showed strong efficacy and safety in ...

A scientist has revealed the shocking way alcohol can increase the risk of deadly cancer. A glass of wine a day doesn't keep ...

A new research perspective was published in , Volume 16, on April 4, 2025, titled "GSK3β activation is a key driver of ...

As early as the 1980s, researchers suspected that alcohol can cause cancer. Epidemiological studies have shown that alcohol is causally linked to cancer of the oral cavity, throat, voice box, ...

RIKEN researchers have discovered how a single mutation in one gene can simultaneously result in two symptoms—a severely ...

Thousands of women with advanced breast cancer in England and Wales are to be offered a "gamechanging" twice-a-day pill on ...

Lung cancer is the number one cancer killer in the world. Biomarker testing improves outcomes in stage IV non-small cell lung cancer (NSCLC), however its ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A twice-a-day pill for the most common type of advanced breast cancer has been approved on the NHS in what scientists say is a “landmark moment”.

Bayer's Vitrakvi receives full FDA approval based on solid tumor data showing sustained efficacy in NTRK fusion-positive patients.

A laboratory on Long Island has found a breakthrough in the fight against pancreatic cancer that can “intercept” its spread.

Researchers have identified mutated proteins strongly linked to bone cancer by constructing a multimodal map of human ...